Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Avalyn Pharma Inc. - common stock (NQ:AVLN)

27.65 -2.08 (-7.00%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 518,810
Open 29.42
Bid (Size) 11.42 (100)
Ask (Size) 44.77 (100)
Prev. Close 29.73
Today's Range 27.36 - 29.42
52wk Range 24.15 - 33.32
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Avalyn Completes Target Enrollment in Phase 2b MIST Trial of AP01 (Inhaled Pirfenidone) for Patients with Progressive Pulmonary Fibrosis
Company expects to report topline 12-month clinical results in the second half of 2027 
From Avalyn Pharma Inc.
Via GlobeNewswire
News headline image
Avalyn Pharma Outlines Inhaled Fibrosis Push After IPO, With Pivotal Data Ahead ↗
Avalyn Pharma (NASDAQ:AVLN) executives outlined the company’s inhaled pulmonary fibrosis strategy at the Jefferies Global Healthcare Conference, emphasizing its recent IPO, ongoing mid-stage studies... 
Via MarketBeat
Topics Initial Public Offering

Performance

YTD
-6.2%
-6.2%
1 Month
-1.5%
-1.5%
3 Month
-6.2%
-6.2%
6 Month
-6.2%
-6.2%
1 Year
-6.2%
-6.2%

More News

Read More
News headline image
Avalyn Reports First Quarter 2026 Financial Results and Recent Business Highlights
From Avalyn Pharma Inc.
Via GlobeNewswire
News headline image
Avalyn to Participate in the Jefferies Global Healthcare Conference
From Avalyn Pharma Inc.
Via GlobeNewswire
News headline image
Avalyn Announces Additional Long-term Data on AP01, Inhaled Pirfenidone, for the Treatment of Pulmonary Fibrosis to be Presented at the European Alliance of Associations for Rheumatology 2026
From Avalyn Pharma Inc.
Via GlobeNewswire
News headline image
Avalyn to Present Patient-Centered Research on AP01 Delivery and Supportive Care Experiences at American Thoracic Society 2026 International Conference
From Avalyn Pharma Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Avalyn Pharma Inc. - common stock publicly traded?
Yes, Avalyn Pharma Inc. - common stock is publicly traded.
What exchange does Avalyn Pharma Inc. - common stock trade on?
Avalyn Pharma Inc. - common stock trades on the Nasdaq Stock Market
What is the ticker symbol for Avalyn Pharma Inc. - common stock?
The ticker symbol for Avalyn Pharma Inc. - common stock is AVLN on the Nasdaq Stock Market
What is the current price of Avalyn Pharma Inc. - common stock?
The current price of Avalyn Pharma Inc. - common stock is 27.65
When was Avalyn Pharma Inc. - common stock last traded?
The last trade of Avalyn Pharma Inc. - common stock was at 07/06/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.